Skip to main content
. Author manuscript; available in PMC: 2018 Jan 14.
Published in final edited form as: J Acquir Immune Defic Syndr. 2016 Oct 1;73(2):e23–e30. doi: 10.1097/QAI.0000000000001115

Table 2.

Baseline socio-demographic and health information for patients on antiretroviral therapy in three health facilities in Mozambique, stratified by randomization to text message group or standard of care, 2011–2013

Standard of care group
(n =414)
Intervention group
(n=412)
Total (n = 830)
n % n % n %
Categorical variables

Health center
Machava II 191 46.1 190 45.7 381 45.9
Matola II 157 37.9 160 38.5 317 38.2
Namaacha 66 15.9 66 15.9 132 15.9
Gender
Male 172 41.5 163 39.2 333 40.1
Female 242 58.5 253 60.8 497 59.9
Education
Illiterate 7 1.7 5 1.2 12 1.7
Primary 305 73.7 305 73.3 610 73.5
Secondary/technical 95 22.9 100 24.0 195 23.5
University 5 1.2 2 0.5 7 0.8
Missing 2 0.5 4 1.0 6 0.7
Marital status
Cohabitating 215 51.9 213 51.2 428 51.6
Single 136 32.9 152 36.5 288 34.7
Married 30 7.2 18 4.3 48 5.8
Widower 33 8.0 31 7.5 64 7.7
Missing 0 0.0 2 0.5 2 0.2
WHO stage
I 146 35.3 148 35.6 294 35.4
II 91 22.0 75 18.0 166 20.0
III 143 34.5 162 38.9 305 36.7
IV 25 6.0 28 6.7 53 6.4
Missing 9 2.2 3 0.7 12 1.4
Continuous variables Median (Q1, Q3) Median (Q1, Q3) Median (Q1, Q3)
Age in years 36.9 (31.3, 45.7) 36.9 (31.2, 43.7) 36.9 (31.3, 44.9)
CD4 cell count (baseline) 304 (196, 468) 320 (202,486) 313 (200, 475)
Time on ART (baseline) in months 13.1 (4.5, 26.5) 14.2 (4.1, 26.7) 13.7 (4.2, 26.6)

Q1: first quartile; Q3: third quartile.